Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis (RAPID-IPF Trial): a study protocol for a randomised controlled trial

Introduction Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is a life-threatening event with high mortality. While systemic corticosteroids are commonly used in clinical practice for AE-IPF despite the absence of randomised evidence, the optimal tapering strategy is uncertain. Early co...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Yuki Kataoka, Yosuke Yamamoto, Masataka Taguri, Kazunori Tobino, Keisuke Anan, Kazuya Ichikado, Kodai Kawamura, Ryo Tachikawa, Chigusa Shirakawa, Takafumi Kawabata
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMJ Publishing Group 2026-06-01
Rangatū:	BMJ Open Respiratory Research
Urunga tuihono:	https://bmjopenrespres.bmj.com/content/13/1/e003818.full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!